During the past decade, Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika" are "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Blood Brain Barrier Defect" (1 trials) and "CNS Lesion" (1 trials). Many other conditions were trialed in "Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika" in a lesser frequency.

Most popular intervention types in "Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Clazosentan" (1 trials), "Gadobutrol 1Mmol/mL Solution for Injection Vial" (1 trials), "Placebo" (1 trials) and "gadopiclenol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pécsi Tudományegyetem Klinikai Központ, Idegsebészeti Klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".